GSK (LSE:GSK) secured Chinese approval for Exdensur for severe asthma patients aged 12 and older. The company also had its ...

GSK has allied with SPH Kyuan Trade, a pharmaceutical import and distribution firm under Shanghai Pharma, to leverage its ...

GSK (GSK.L) on Monday unveiled regulatory updates for its drug portfolio in China, with its asthma medication Exdensur approved and its chronic hepatitis B treatment bepirovirsen accepted for review.

The treatment, an ultra-long-acting biologic, was given the green light by the National Medical Products Administration for patients aged 12 years and older as an add-on maintenance treatment of ...

China NMPA accepts for review GSK’s NDA for bepirovirsen, an investigational ASO to treat adults with chronic hepatitis B: London, UK Tuesday, March 31, 2026, 16:00 Hrs [IST] GS ...

(Alliance News) - GSK PLC on Monday reported regulatory momentum in China for its drugs Exdensur and bepirovirsen. The pharmaceutical firm's shares were up 0.5% to 2,060.00 pence on Monday morning in ...

British pharma major GSK (LSE: GSK) is bringing its hepatitis B vaccine Engerix B (hepatitis B vaccine) back to China through ...

GSK’s Exdensur receives China NMPA approval for the treatment of severe asthma: London, UK Tuesday, March 31, 2026, 09:00 Hrs [IST] GSK plc, a global biopharma company, announce ...

LONDON — UK pharmaceutical company GlaxoSmithKline distanced itself Wednesday from the scandal engulfing its operations in China, saying that four employees suspected of paying bribes were acting ...

SHANGHAI/LONDON (Reuters) - GlaxoSmithKline Plc's tangled web of problems in China, including a sex video of its former China chief and anonymous emails alleging corruption, are highlighted in a ...